Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELASTIC: Roflumilast and subclinical atherosclerosis in stable COPD
2011-004152-19Phase 2Completed
- Sponsor
- Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology. Started Feb 2012; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2011-004152-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004152-19.